NCT02280694View on ClinicalTrials.gov

Low Dose Metronomic Poly-chemotherapy for Metastatic CRC

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

December 31, 2019

Conditions
Colorectal Cancer
Interventions
DRUG

Capecitabine

DRUG

Cyclophosphamide

DRUG

Methotrexate

DRUG

Celecoxib

Trial Locations (1)

Unknown

Gastrointestinal Oncology Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center, Belinson Campus,, Petach Tiqva

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT02280694 - Low Dose Metronomic Poly-chemotherapy for Metastatic CRC | Biotech Hunter | Biotech Hunter